Download Citation
Article Source:
Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
Achhra AC,
Boyd MA,
Law MG,
Matthews GV,
Kelleher AD,
et al.
(2014)
Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial.
PLOS ONE 9(6): e99530.
https://doi.org/10.1371/journal.pone.0099530